BMY - Bristol Myers Squibb Company Stock Trading

Bristol-Myers Squibb Company(NYSE: BMY) stock trading, description, contact, officers and directors.

About Bristol-Myers Squibb Company

Not available

Stock Information

Bristol-Myers Squibb Company Company Name:

BMY Stock Symbol:

NYSE Market:

Get BMY Alerts

News, Short Squeeze, Breakout and More Instantly...

BMY - Opdivo (nivolumab) Significantly Improves Disease Free-Survival vs. Placebo as Adjuvant Therapy for Patients with High-Risk, Muscle-Invasive Urothelial Carcinoma in Phase 3 CheckMate -274 Trial

In an interim analysis, CheckMate -274 met primary endpoints of disease-free survival in both all randomized patients and in patients whose tumor cells express PD-L1 ≥1% Opdivo has now demonstrated clinically meaningful efficacy in the adjuvant treatment of three ...
BMY - FDA Accepts Application for Bristol-Myers Squibb and bluebird bio's Multiple Myeloma CAR-T Therapy

A novel approach to multiple myeloma treatment developed by Bristol-Myers Squibb (NYSE: BMY) and bluebird bio (NASDAQ: BLUE) took an important step toward commercialization on Tuesday when the Food and Drug Administration announced that it had accepted their application for ...
BMY - U.S. Food and Drug Administration (FDA) Accepts for Priority Review Bristol Myers Squibb and bluebird bio Application for Anti-BCMA CAR T Cell Therapy Idecabtagene Vicleucel (Ide-cel, bb2121)

FDA set a target action date of March 27, 2021 Ide-cel is the first CAR T cell therapy accepted for regulatory review for multiple myeloma Bristol Myers Squibb (NYSE: BMY) and bluebird bio, Inc . (Nasdaq: BLUE) today announced that the U.S. Fo...